Use of carbon dioxide as an alternative contrast agent for angiography in patients with critical limb ischemia and chronic kidney disease
Clinical Endocrinology and Endocrine Surgery · 30.06.2026 · (2) · 34-40
DOI: 10.30978/cees-2026-2-34 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology and Endocrine Surgery, online erschienen am 30.06.2026. Verfasst von I. L. Savon und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Peripheral artery disease is a chronic disease of the lower limb arteries due to atherosclerosis. Surgical treatment involves eliminating arterial occlusion by performing «open» surgery, endovascular intervention, or a combination of these methods. Endovascular revascularization methods are minimally invasive, are associated with fewer complications compared to open surgery, and both short- and long-term outcomes are comparable. Many patients with peripheral artery disease have chronic kidney disease, which increases the risk of developing contrast-induced nephropathy, which occurs after intravascular administration of iodinated radiocontrast agents. The use of CO2 as a contrast agent is considered an alternative.
Objective
To evaluate the safety and effectiveness of imaging using CO2 as a contrast agent for angiography in patients with critical limb ischemia and chronic renal failure. Materials and methods. In 2023 — 2025, a comparison was made between two groups of patients with critical limb ischemia and concomitant renal failure who underwent endovascular treatment. In the main group (n=32), CO2 was used as a contrast agent during endovascular treatment, while in the control group (n=35), an iodine-containing contrast agent, iohexol («Tomogexol» solution for injection (350 mg iodine), «Farmak», Ukraine), was used. Comprehensive examination and treatment were carried out in accordance with international recommendations and protocols approved at the Center. The groups did not differ significantly in age, sex distribution, body weight, Fontaine classification stage (1954), or predominant localization of lower extremity arterial lesions (p>0.05). In the main group, creatinine levels significantly exceeded those in the control group (189.21±5.57 and 86.23±4.84 µmol/L, p < 0.0001), and the glomerular filtration rate was almost three times lower (37.19±2.75 and 97.78±3.54 mL/(min · 1.73 m2), p < 0.0001). The indication for CO2-angiography was impaired kidney function (creatinine level > 130 µmol/L and glomerular filtration rate < 59 mL/(min · 1.73 m2)).
Results
Endovascular procedures using iodine-containing contrast were performed according to standard methodology using a «Philips Allura Xper CV20» angiograph (Netherlands). During carboxyangiography, CO2 was delivered into the arterial bed using «Angioset» (Optimed, Germany). The volume of CO2 used in the main group was 441.87±21.77 mL, iohexol was 17.21±0.62 mL, and iohexol in the control group was 175.71±7.96 mL (p < 0.0001). To monitor patient exposure, fluoroscopy duration and cumulative dose were determined. The groups did not differ significantly in fluoroscopy duration (28.18±1.72 and 27.42±1.59 min, p=0.066). The cumulative radiation dose in the main group did not differ significantly from that in the control group (431.11±1.87 and 430.91±2.54 mGy, t=0.37; p=0.71). In all patients of the main group, the procedure using CO2 was accompanied by peripheral nerve blockade of the lower limb, while in the control group, it was only in 17 (48.5%) cases (p < 0.0001). In patients who underwent CO2-angiography, a low frequency of non-renal complications (limb pain, nausea) was observed; no other CO2-related side effects were reported.
Conclusions
The use of CO2 as a contrast agent provides sufficient resolution for diagnostic and therapeutic endovascular procedures. The use of this gas represents an effective preventive measure against contrast-induced nephropathy. Modern CO2 delivery systems and improved imaging technologies have expanded the possibilities of using CO2-angiography in patients with peripheral artery disease and renal failure as a safe alternative to using iodinated contrast agents. Combined angiography, which uses CO2 and a small amount of iodine-containing contrast, helps avoid adverse events and obtaining good image quality.
Zitieren
APA
Savon, I. L., Hyndych, P. A., Denysov, S. Y., Prystupiuk, M. O., & Maksymova, O. O. (2026). Use of carbon dioxide as an alternative contrast agent for angiography in patients with critical limb ischemia and chronic kidney disease. Clinical Endocrinology and Endocrine Surgery, 34-40. https://doi.org/10.30978/cees-2026-2-34
Vancouver
Savon IL, Hyndych PA, Denysov SY, Prystupiuk MO, Maksymova OO. Use of carbon dioxide as an alternative contrast agent for angiography in patients with critical limb ischemia and chronic kidney disease. Clinical Endocrinology and Endocrine Surgery. 2026:34-40. doi:10.30978/cees-2026-2-34
BibTeX
@article{Savon2026,
author = {Savon, I. L. and Hyndych, P. A. and Denysov, S. Y. and Prystupiuk, M. O. and Maksymova, O. O.},
title = {Use of carbon dioxide as an alternative contrast agent for angiography in patients with critical limb ischemia and chronic kidney disease},
journal = {Clinical Endocrinology and Endocrine Surgery},
year = {2026},
number = {2},
pages = {34--40},
doi = {10.30978/cees-2026-2-34}
}
EUVIMED